In the BioHarmony Drug Report Database
Levobetaxolol
Betaxon (levobetaxolol) is a small molecule pharmaceutical. Levobetaxolol was first approved as Betaxon on 2000-02-23. It is used to treat ocular hypertension and open-angle glaucoma in the USA. The pharmaceutical is active against beta-1 adrenergic receptor. In addition, it is known to target beta-2 adrenergic receptor.
Trade Name
|
Betaxon |
|---|---|
Common Name
|
levobetaxolol |
ChEMBL ID
|
CHEMBL1201274 |
Indication
|
ocular hypertension, open-angle glaucoma |
Drug Class
|
Beta-blockers (propranolol type) |
Image (chem structure or protein)